11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
View Patent ↗A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11 β-hydroxy-Steroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.
1. A compound selected from the group consisting of:
2,3-Dihydrospiro(1-methanesulfonyl-indol-3,4′-piperidin-1-yl)-(1H-indol-5-yl)-methanone;
2,3-Dihydrospiro(1-methanesulfonyl-indol-3,4′-piperidin-1-yl)-(3-N,N-dimethylamino-phenyl)-methanone; and
2,3-Dihydrospiro(1-methanesulfonyl-indol-3,4′-piperidin-1-yl)-(benzimidazol-5-yl)-methanone; or
a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier or excipient.